Infiltrative-Suppurative Form of Scalp Microsporia in a Child with Generalized Pustular Psoriasis of von Zumbusch: Clinical Case
https://doi.org/10.15690/vsp.v20i5.2316
Abstract
Background. This article discusses issues of diagnosis and management of pustular psoriasis in a child associated with recurrent dermatomycosis, immunopathogenetic mechanisms of pustular psoriasis, its course and prognosis. Clinical Case Description. The clinical case of infiltrative-suppurative form of scalp microsporia in 11 years old child with long-term psoriasis vulgaris and its transformation to generalized pustular psoriasis (von Zumbusch) is described. The need of immunosuppressive therapy prescription for severe psoriasis was challenged with fungal skin infection as immune suppression would lead to its recurrent course. Conclusion. Combination treatment (systemic glucocorticosteroids, methotrexate, antibiotics, and griseofulvin) resulted in clinical and laboratory recovery for microsporia in a child with generalized pustular psoriasis.
Keywords
Supporting agencies: Not specified.
About the Authors
Andrey L. Bakulev
Saratov State Medical University n.a. V.I. Razumovsky
Russian Federation
Disclosure of interest:
Russian Federation
Saratov.
Disclosure of interest:
Andrey L. Bakulev — conducting clinical studies with such companies as MSD, Janssen, AbbVie, LEO Pharma, UCB, BIOCAD, Dr. Reddy's Laboratories Ltd., Novartis, AMGen, Galderma, Veropharm, Pfizer, UCB. Scientific assessment of data for Eli Lilly, Janssen, AbbVie, LEO Pharma, UCB, BIOCAD, Novartis, AMGen, Galderma, Zeldis Pharma. Lecturing for Eli Lilly, Bayer, MSD, Janssen, AbbVie, LEO Pharma, UCB, BIOCAD, Dr. Reddy's Laboratories Ltd., Novartis, Galderma, Veropharm, Pfizer, Jadran (JGL), Zeldis Pharma.
Sergey S. Kravchenya
Saratov State Medical University n.a. V.I. Razumovsky
Russian Federation
Disclosure of interest:
Russian Federation
Saratov.
Disclosure of interest:
No conflict of interests.
Irina A. Igonina
Saratov State Medical University n.a. V.I. Razumovsky
Russian Federation
Disclosure of interest:
Russian Federation
Saratov.
Disclosure of interest:
No conflict of interests.
References
1. Hoegler KM, John AM, Handler MZ, et al. Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Dermatol Venereol. 2018;32(10):1645-1651. doi: 10.1111/jdv.14949
2. Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620-628.
3. Johnston A, Xing X, Wolterink L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109-120. doi: 10.1016/j.jaci.2016.08.056
4. Hussain S, Berki DM, Choon SE, et al. IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis. J Allergy Clin Immunol. 2015;135(4):1067-1070 e9.
5. Berki DM, Liu L, Choon SE, et al. Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris. J Invest Dermatol. 2015;135(12):2964-2970.
6. Onoufriadis A, Simpson MA, Pink AE, et al. Mutations in IL36RN/ IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011;89(3):432-437.
7. Namba C, Murakami M, Hanakawa Y, et al. Infantile generalized pustular psoriasis: successful disease control with intermittent etretinate. J Dermatol. 2014;41(5):403-406.
8. Horreau C, Pouplard C, Brenaut E, et al. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013:27(Suppl 3):12-29.
9. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using the General Practice Research Database. Eur Heart J. 2010;31(8):1000-1006.
10. Jin H, Cho HH, Kim WJ, et al. Clinical features and course of generalized pustular psoriasis in Korea. J Dermatol. 2015;42:674-678.
11. Choon SE, Lai NM, Mohammad NA, et al. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: Analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2014;53(6):676-684.
12. Tay YK, Tham SN. The profile and outcome of pustular psoriasis in Singapore: A report of 28 cases. Int J Dermatol. 1997;36(4):266-271.
13. Zelickson BD, Muller SA. Generalized pustular psoriasis: A review of 63 cases. Arch Dermatol. 1991;127(9):1339-1345.
14. Robinson A, Van Voorhees AS, Hsu S, et al. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012;67(2):279-288.
15. Yi-Wei Huang, Tsen-Fang Tsai. Pharmacological Management of Pediatric Pustular Psoriasis. Paediatr Drugs. 2020;22(3):265-277. doi: 10.1007/s40272-020-00383-6
16. Gooderham MJ, Van Voorhees AS, Lebwohl MG. An update on generalized pustular psoriasis. Expert Rev Clin Immunol. 2019;15(9):907-919. doi: 10.1080/1744666X.2019.1648209
17. Levin EC, Debbaneh M, Koo J, et al. Biologic therapy in erythro-dermic and pustular psoriasis. J Drugs Dermatol. 2014;13(3):342-354.
18. Imafuku S, Honma M, Okubo Y, et al. Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study. J Dermatol. 2016;43(9):1011-1017. doi: 10.1111/1346-8138.13306
19. Sakai H, Nomura W, Fukushima H, et al. Terbinafine-induced generalized pustular psoriasis in a patient carrying CARD14 mutation. J Dermatol. 2019;46(3):110-112. doi: 10.1111/1346-8138.14608
20. Kim BS, Jang HS, Jwa SW, et al. Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy. J Korean Med Sci. 2007;22(1):167-169.
Review
For citations:
Bakulev A.L., Kravchenya S.S., Igonina I.A. Infiltrative-Suppurative Form of Scalp Microsporia in a Child with Generalized Pustular Psoriasis of von Zumbusch: Clinical Case. Current Pediatrics. 2021;20(5):413-417. (In Russ.) https://doi.org/10.15690/vsp.v20i5.2316
Views:
694
Email this article 
